Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
10:16am, Thursday, 02'nd Oct 2025
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.
Illumina launches new business to accelerate technology and data-driven discovery
09:05am, Wednesday, 01'st Oct 2025
New business focuses on developing data assets, software, and AI to fuel life science breakthroughs Expands pharma access to large omics datasets to advance target discovery and drug development SAN
KMDA vs. ILMN: Which Stock Is the Better Value Option?
12:40pm, Monday, 29'th Sep 2025
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Kamada (KMDA) and Illumina (ILMN). But which of these two stocks offers value investors a better ban
TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?
10:26am, Friday, 26'th Sep 2025
Investors are showing growing interest in the rapidly expanding Precision Oncology market, which is expected to witness a compound annual growth rate (CAGR) of 8% between 2025 and 2030, according to G
ILMN Stock vs. IQV Stock
09:40am, Friday, 26'th Sep 2025
Amid increased competition from China's MGI Tech, Illumina's stock (NASDAQ: ILMN) has dropped by 11% in a week. MGI Tech's DNA sequencers are reportedly gaining market share, and despite a recent decl
Here's Why Illumina (ILMN) is a Strong Momentum Stock
10:50am, Tuesday, 23'rd Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Illumina advances personalized cancer care with new pharma development partnerships
09:15am, Tuesday, 23'rd Sep 2025
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO , Sept. 23, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) will partner with mul
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
09:15am, Thursday, 18'th Sep 2025
Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicines Members leverage AI-powered dataset to accelerate pharma R&D
ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay
09:05am, Tuesday, 09'th Sep 2025
The Illumina Protein Prep rollout boosts multiomics, strengthens disease insights and supports ILMN stock momentum.
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
09:15am, Wednesday, 03'rd Sep 2025
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, custome
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 01'st Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
04:11pm, Thursday, 14'th Aug 2025
Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem's financial team POMPANO BEACH, FL, August 14, 2
KMDA vs. ILMN: Which Stock Is the Better Value Option?
12:40pm, Thursday, 14'th Aug 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for thei
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know
10:16am, Tuesday, 05'th Aug 2025
Evaluate Illumina's (ILMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
